PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE. (12th June 2019) - Janikova, A.; Chloupkova, R.; Campr, V.; Kopalova, N.; Klener, P.; Benesova, K.; Hamouzova, J.; Belada, D.; Sykorova, A.; Prochazka, V.; Pirnos, J.; Duras, J.; et al.